Scope of this article
This content is not diagnosis, prescribing, personal risk assessment or a treatment plan. Sources may be limited to a particular product, device, task, indication or study group.
This translation is provided for general access and has no recorded medical-language review.
Editorial general information — not a clinical-review record
Published: Updated: Publisher: Dr. Murat Toktamışoğlu
Brief redness can occur after HIFU, but marked pain, blistering, sharply demarcated pallor or darkening, crusting and an open wound should not be treated as routine recovery. Timing, contact, transducer, energy and co-applied products need assessment together.
This translation has no recorded clinical or medical-language review.
Distinguish mild, resolving redness and warmth from intense or persistent pain, a fluid-filled blister, mottling, an open wound or evolving discoloration. Record onset, progression, distribution, sensation and muscle function. Early erythema can be harder to see in darker skin, so assessment should not rely on colour alone; temperature, tenderness, pain and tissue integrity also matter.
Preserve the device, software, transducer or cartridge, lot or serial, energy, depth, lines, passes and treatment-area record. Consider transducer damage, inadequate or incompatible coupling, incomplete contact over a fold and repeated delivery at the same point. No single finding automatically proves cause; maintenance logs and manufacturer investigation may be needed.
Do not rely on online product advice when there is an open wound, possible infection, rapidly worsening pain or a neurological sign. Clinical assessment determines injury depth, possible eye or nerve involvement and the appropriate care pathway. Keep standardized photographs, interventions and healing course. Scar and pigment-change risk differs by person, and permanence cannot be predicted from an early appearance alone.
This content is not diagnosis, prescribing, personal risk assessment or a treatment plan. Sources may be limited to a particular product, device, task, indication or study group.
These links are editorial starting points used to examine the article's boundaries.
Contini M, Hollander MHJ, Vissink A, Schepers RH, Jansma J, Schortinghuis J · 2023
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Ling J, Zhao H · 2023
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Riopelle AM, Geisler AN, Eber A, Dover JS · 2025
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Niu Z et al. · 2021
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
U.S. Food and Drug Administration (FDA) · 2023
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
U.S. Food and Drug Administration (FDA) · 2026
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Systematic review authors; Aesthetic Surgery Journal · 2025
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review